Jurgen Kuball

UMC Utrecht

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Christian Chabannon

Professor in Cell Biology

Aix-Marseille Université Faculté de Medecine

FRANCE

View details

Maria Salgado

SPAIN

View details

Asier Sáez-Cirión

Institut Pasteur

FRANCE

View details

Tassilo Leo Alexander Wachsmann

Leiden University Medical Center

NETHERLANDS

View details

Toine Egberts

Utrecht University

NETHERLANDS

View details

Isabel Salcedo de Diego

Universidad Autónoma de Madrid

SPAIN

View details

Fermin Sanchez-Guijo

Full-Professor of Medicine (Catedrático de Medicina)

Universidad de Salamanca

SPAIN

View details

Joaquim Vives

Associate Medical Lecturer (external)

University of Barcelona

SPAIN

View details

Mirjam H.M. Heemskerk

Associate professor, Head of Laboratory of experimental hematology

Leiden University Medical Center

NETHERLANDS

View details

Javier Martinez-Picado

Associate professor

SPAIN

View details

Jaime Sanz

Profesor asociado asistencial

Universidad Católica de Valencia Facultad de Medicina

SPAIN

View details

Jeanette Leusen

professor

University Medical Center Groningen

NETHERLANDS

View details

Mette D. Hazenberg

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jurgen Kuball

Research Interests

Explore related searches

Contact this professor

Articles (12)

Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)

Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen

Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT

Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosis

Graft engineering: how long can you wait, how low can you go, and pandemic readiness

Activity of ex vivo graft and DLI Engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Serpin B9 controls tumor cell killing by CAR T cells

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Correction to: Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients

Collaborators (13)

Christian Chabannon

Maria Salgado

Asier Sáez-Cirión

Tassilo Leo Alexander Wachsmann

Toine Egberts

Isabel Salcedo de Diego

Fermin Sanchez-Guijo

Joaquim Vives

Mirjam H.M. Heemskerk

Javier Martinez-Picado

Jaime Sanz

Jeanette Leusen

Mette D. Hazenberg

Make your next move.